On Friday, March 7 Phoenix Rising research reporter Cort Johnson hosted a Live Chat Q&A in the ImmuneSupport.com Community Chat Room. The exchange covered a lot of ground – and still only scratched the surface of Cort's impressive knowledge and generosity. You can now read the full script of the Q&A in the March 26 issue of ProHealth's ME/CFS HealthWatch Newsletter, and it will be featured in the April 2 issue of our FM HealthWatch Newsletter.
Cort Covers the Research Beat
Cort Johnson specializes in plain-language reporting on the latest research, via his Phoenix Rising website and newsletter dedicated to helping patients with chemical sensitivities, ME/CFS, and FM. In his search for news, Cort tracks down and highlights the latest ideas, interviews the doctors, investigates different therapies, and has tried more than a few himself.
What Does He Know? You Name It
Cort follows the science on environmental illness, toxins, and MCS, chronic infection and immune activation research, Fibromyalgia pain theories, treatments of all kinds, testing, the controversies over diagnostic criteria and a new name for CFS, views on the various “cellular energy boosters,” orthostatic intolerance (problems when standing up), glutathione depletion, melatonin – and many other topics routinely discussed in the ImmuneSupport.com Message Boards.
See For Example:
n Cort’s personal story, explaining his particular interest in chemical sensitivities and biotoxins – “Cort Johnson: Making ME/CFS Research Readable and Accessible.”
n “Taking Stock: ME/CFS Advocacy Making Headway” – How the CDC funding scandal helped promote ME/CFS, and a lot of reasons to be optimistic.
n “The Infection Connection: Dumbfounded in Dubbo” – Cort's explanation of seeming conflicts in the high-profile Australian studies of infection, immune response, and genes, in the current issue of Phoenix Rising.
n “An Interview with researcher Suzanne Vernon, PhD”, who as organizer of the CDC’s ME/CFS research lab put the disease in the limelight, and now as Scientific Director of the CFIDS Association envisions a research “revolution” involving networks of researchers around the world studying the similar abnormalities of ME/CFS, FM, and other diseases.
n “The Do Nothing Program: Getting the Answers” – “Why are one or two or three studies funded a year in a disease that affects millions acceptable to the NIH?" Cort asks in this challenging testimony, delivered during the November CFS Advisory Committee’s report to the NIH.